SCHEMBL681563

SCHEMBL681563

C=C(C(C)C)C(CNCC(F)(F)F)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.42
AKT3 Q9Y243 3/20 0.42
AKT2 P31751 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.38
FFAR2 O15552 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
TP53 P04637 1/20 0.34
MDM2 Q00987 1/20 0.34
CTSS P25774 1/20 0.34
HTRA1 Q92743 1/20 0.34
CNR2 P34972 1/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12194476 0.87 FFAR2 (0.38) AKT1AKT3AKT2SMN1; SMN2FFAR2
SCHEMBL681180 0.86 AKT1 (0.44) AKT1AKT3AKT2SMN1; SMN2FFAR2
SCHEMBL12188337 0.83 AKT1 (0.46) AKT1AKT3AKT2SMN1; SMN2FFAR2
SCHEMBL12194498 0.82 FFAR2 (0.41) AKT3AKT2SMN1; SMN2FFAR2L3MBTL1
SCHEMBL681742 0.82 AKT1 (0.41) AKT1AKT3AKT2SMN1; SMN2FFAR2
SCHEMBL191445 0.81 L3MBTL1 (0.51) AKT1AKT3AKT2SMN1; SMN2FFAR2
SCHEMBL2738565 0.80 AKT1 (0.43) AKT1AKT3AKT2SMN1; SMN2FFAR2
Potassium Ion SCHEMBL191383 0.79 AKT1 (0.43) AKT1AKT3AKT2SMN1; SMN2FFAR2
SCHEMBL681142 0.78 KMT2A (0.42) FFAR2L3MBTL1POLBCYP2D6SLC6A2
SCHEMBL681371 0.78 KMT2A (0.42) FFAR2L3MBTL1POLBCYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed